Histone Methylation by Temozolomide; a Classic DNA Methylating Anticancer Drug

Total Page:16

File Type:pdf, Size:1020Kb

Histone Methylation by Temozolomide; a Classic DNA Methylating Anticancer Drug ANTICANCER RESEARCH 36: 3289-3300 (2016) Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug TIELI WANG1, AMANDA J. PICKARD2 and JAMES M. GALLO2 1Department of Chemistry and Biochemistry, California State University Dominguez Hills, Carson, CA, U.S.A.; 2Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A. Abstract. Background/Aim: The alkylating agent, adults (1). Despite advances in multimodal therapies of temozolomide (TMZ), is considered the standard-of-care for surgical extirpation, radiotherapy and chemotherapy, GBMs high-grade astrocytomas –known as glioblastoma multiforme remain a cancer of poor prognosis that can be attributed to (GBM)– an aggressive type of tumor with poor prognosis. The the aggressive nature of the tumors and the development of therapeutic benefit of TMZ is attributed to formation of DNA resistance to radiation and chemotherapy (2). Out of adducts involving the methylation of purine bases in DNA. We chemotherapeutic approaches to GBMs, temozolomide investigated the effects of TMZ on arginine and lysine amino (TMZ) is the main alkylating agent used, based on its ability acids, histone H3 peptides and histone H3 proteins. Materials to increase the median survival (3-6). and Methods: Chemical modification of amino acids, histone TMZ possesses favorable pharmacokinetic characteristics H3 peptide and protein by TMZ was performed in phosphate with high oral bioavailability and blood-brain barrier (BBB) buffer at physiological pH. The reaction products were penetration (7). TMZ is a prodrug that undergoes pH- examined by mass spectrometry and western blot analysis. dependent degradation, first producing 5-(3-methyltriazen-1- Results: Our results showed that TMZ following conversion to yl)imidazole-4-carboxamide (MTIC), that is subsequently a methylating cation, can methylate histone H3 peptide and degraded into 4-amino-5-immidazole-carboxamide (AIC) – an histone H3 protein, suggesting that TMZ exerts its anticancer inactive metabolite and a methyldiazonium cation, the activity not only through its interaction with DNA, but also methylating agent (Figure 1). The anticancer effects of TMZ through alterations of protein post-translational modifications. are attributed to the methylation of DNA by TMZ with the Conclusion: The possibility that TMZ can methylate histones primary cytotoxic lesion being O6-methylguanine (O6-MeG); involved with epigenetic regulation of protein indicates a N7-methylguanine, N3-methylguanine, and N3-methyladenine potentially unique mechanism of action. The study will (8-10) adducts also contribute to the cytotoxicity. The DNA contribute to the understanding the anticancer activity of TMZ adducts can lead to single- and double-strand DNA breaks and in order to develop novel targeted molecular strategies to eventually apoptosis; however, numerous DNA repair systems, advance the cancer treatment. highlighted by the methylguanine methyltransferase (MGMT) enzyme that repairs the O6-MeG lesions, can result in Malignant gliomas, or glioblastoma multiforme (GBM), are chemoresistance (11-13). Other DNA repair processes, such as the most common primary brain malignancies found in mismatch repair (MMR) and base excision repair (BER), also influence cellular resistance to TMZ. The field of epigenetics characterizes how chemical and enzymatic modifications to DNA and histones occur and This article is freely accessible online. their subsequent impact on gene expression. In fact, Correspondence to: Tieli Wang, Department of Chemistry and hypermethylation of the MGMT promoter in GBM patients Biochemistry, California State University Dominguez Hills, Carson, (14, 15, 16) is used as a favorable prognostic biomarker and CA, U.S.A. Tel: 310 2433388, Fax: 310 2432593, e-mail: increases drug sensitivity since a lower amount of the [email protected] and James M. Gallo, Department of enzyme is available to repair TMZ-induced lesions (17). Pharmacology and Systems Therapeutics, Icahn School of Medicine Although DNA methylation has been shown to affect at Mount Sinai, New York, NY, U.S.A. Tel: 212 2413980, Fax: 212 chromatin structure and influence histone methylation (18), it 9967214, e-mail: [email protected]. is direct enzymatic modification of histones, such as Key Words: Temozolomide, malignant gliomas, chemotherapy, methylation and acetylation that are considered crucial to histone methylation. gene expression. 0250-7005/2016 $2.00+.40 3289 ANTICANCER RESEARCH 36: 3289-3300 (2016) Figure 1. TMZ metabolic cascade at physiological pH to 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC) and its metabolites, 4-amino-5- imidazole-carboxamide (AIC) and methyldiazonium ion. In the current study, we addressed whether TMZ can reaction mixture was centrifuged in an Amicon Ultra-0.5 centrifugal methylate histones directly, by examining the effects of TMZ filter device (EMD Millipore, Billerica, MA, USA) at 4˚C at 14,000 × on amino acids, peptides and histone proteins in vitro using g with a 40˚ fixed angle rotor to concentrate the protein samples and remove low molecular weight impurities and unreacted TMZ. The 100 mass spectrometry and protein biochemical methods. Our μg concentrated protein solution was resuspended in 100 μl 0.01 M results demonstrated that TMZ is able to methylate histone phosphate buffer (pH 7.4). Western blot analysis was then used to proteins under physiological conditions. The possibility that confirm the methylated histone H3 protein. this action could occur in GBM patients opens a new avenue of investigation to determine its significance. Mass spectrometry. Mass spectrometry experiments were performed using a QTRAP 5500 triple quadrupole mass spectrometer (AB Materials and Methods SCIEX, Framingham, MA, USA) coupled to a Shimadzu Prominence UFLC system (Shimadzu Corp., Torrance, CA, USA). The system was continuously supplied with ultra-high purity Chemicals and general procedures. Arginine, lysine and TMZ nitrogen, dry air, and zero air by a Source 5000 LC-MS TriGas (>98%) were purchased from Sigma-Aldrich Co. (St. Louis, MO, generator (Parker Hannifin Corp., Haverhill, MA, USA). The USA). Histone H3 (1-8) peptide H2N-ARTKQTAR-COOH (>95% QTRAP 5500 system was equipped with an electrospray ionization by HPLC, MW=931.1 g/mol) was purchased from AnaSpec, Inc. (ESI) TurboIon Spray probe utilizing zero grade air as the nebulizer (Fremont, CA, USA). Xenopus recombinant histone H3 (C110A) (Gas 1) and heater (Gas 2) gases. Ultra-high purity nitrogen was (>98% by SDS-PAGE, MW=15,239 Da), supplied as a lyophilized used as the curtain (CUR) and collision (CAD) gases. Mass powder, was purchased from Active Motif (Carlsbad, CA, USA). spectrometer control and spectral processing were carried out using Recombinant human histone H3.1 protein (MW=15273.2 Da by Analyst 1.5.2 software (AB SCIEX). Mass spectrometer parameters ESI-TOF) was purchased from New England BioLabs, Inc. were optimized for each compound analyzed (Tables I and II). A (Ipswich, MA, USA). Human recombinant histone H3 protein 1μl sample of unreacted amino acid, TMZ, or the reaction mixture (≥95% by SDS-PAGE, MW=15,500 Da by SDS-PAGE) was was introduced into the electrospray source by direct injection. The purchased from Cayman Chemical Co. (Ann Arbor, MI, USA) as a mobile phase consisted of 50% methanol with 0.1% formic acid and lyophilized powder. All buffers and mobile phases were prepared 50% water with 0.1% formic acid and was maintained at a constant using analytical grade reagents and ultrapure water from a Millipore flow rate of 200 μl/min. Unreacted and reacted peptide solutions Synergy UV water filtration system (EMD Millipore, Billerica, MA, were infused directly into the electrospray source at a flow rate of 7 USA) at a resistivity of 18 MΩ·cm. All reagents were used without μl/min. All mass spectra were acquired in positive-ion mode with further purification. The pH measurements were measured using a unit mass resolution. Mass spectra for the free amino acid studies calibrated Fisher Scientific AccuMet Basic AB15 pH MV benchtop were background-subtracted with a spectrum obtained of 100 μM pH meter (Fisher Scientific, Pittsburgh, PA, USA). TMZ in 50/50 0.01 M phosphate buffer/methanol (v/v). Peptides were fragmented under conditions with the collision Reactivity of amino acids and peptides with TMZ. Separate stock energy between 15 to 45 eV by the direct infusion method at a flow solutions of arginine (0.5 mM), lysine (0.5 mM), TMZ (0.2 mM) rate of 7 μl/min. The MS/MS spectra were interpreted manually, and histone H3 (1-8) peptide (10 mg/ml) were prepared in 0.01 M primarily by assigning the peaks corresponding to the C-terminal y- phosphate buffer (pH 7.4) and kept at 4˚C until use. A solution ions. The modification was mapped based on the mass difference of containing 10 μM amino acid or peptide and 200 μM TMZ was the y ions in the spectrum derived from the doubly charged mixed at room temperature for 24 h. Subsequently an aliquot of the precursor ions when compared to the y ions in the spectrum of solution was diluted 1:1 with methanol and was passed through a unmethylated peptide. Mass spectrometer parameters were 0.22 μm syringe filter. The filtered solution was subsequently optimized for each methylated peptide analyzed (Table III). Mass analyzed by LC-MS/MS. fragmentation prediction was generated using Mascot (Matrix Science, London, UK). Reactivity of histone H3 Proteins with TMZ. 100 μg of histone H3 Western blot analysis. Standard protein electrophoresis conditions and protein was resuspended in 100 μl 0.01 M phosphate buffer (pH 7.4) reagents were used for gel and sample preparation. Recombinant and 10 μM TMZ in 0.01 M (pH 7.4) phosphate buffer was mixed with proteins (0.5-5 μg) and the LI-COR Chameleon Duo ladder (LI-COR the protein solution at room temperature for 24 h. The resultant Biosciences, Inc., Lincoln, NE) were loaded onto a 12% Mini-Protean- 3290 Wang et al: Protein Methylation by Temozolomide Table I.
Recommended publications
  • The Cross-Talk Between Methylation and Phosphorylation in Lymphoid-Specific Helicase Drives Cancer Stem-Like Properties
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans ARTICLE OPEN The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties Na Liu1,2,3, Rui Yang1,2, Ying Shi1,2, Ling Chen1,2, Yating Liu1,2, Zuli Wang1,2, Shouping Liu1,2, Lianlian Ouyang4, Haiyan Wang1,2, Weiwei Lai1,2, Chao Mao1,2, Min Wang1,2, Yan Cheng5, Shuang Liu4, Xiang Wang6, Hu Zhou7, Ya Cao1,2, Desheng Xiao1 and Yongguang Tao1,2,6 Posttranslational modifications (PTMs) of proteins, including chromatin modifiers, play crucial roles in the dynamic alteration of various protein properties and functions including stem-cell properties. However, the roles of Lymphoid-specific helicase (LSH), a DNA methylation modifier, in modulating stem-like properties in cancer are still not clearly clarified. Therefore, exploring PTMs modulation of LSH activity will be of great significance to further understand the function and activity of LSH. Here, we demonstrate that LSH is capable to undergo PTMs, including methylation and phosphorylation. The arginine methyltransferase PRMT5 can methylate LSH at R309 residue, meanwhile, LSH could as well be phosphorylated by MAPK1 kinase at S503 residue. We further show that the accumulation of phosphorylation of LSH at S503 site exhibits downregulation of LSH methylation at R309 residue, which eventually promoting stem-like properties in lung cancer. Whereas, phosphorylation-deficient LSH S503A mutant promotes the accumulation of LSH methylation at R309 residue and attenuates stem-like properties, indicating the critical roles of LSH PTMs in modulating stem-like properties. Thus, our study highlights the importance of the crosstalk between LSH PTMs in determining its activity and function in lung cancer stem-cell maintenance.
    [Show full text]
  • Amino Acid Building Block Models – in Brief
    Amino Acid Building Block Models – In Brief Key Teaching Points for Amino Acid Building Block Models© Overall Student Learning Objective: What Dictates How a Protein Folds? Amino acids are the building blocks of proteins. All amino acids have an identical core structure consisting of an alpha-carbon, carboxyl group, amino group and R-group (sidechain). A linear chain of amino acids is a polypeptide. The primary sequence of a protein is the linear sequence of amino acids in a polypeptide. Proteins are made up of amino acid monomers linked together by peptide bonds. Peptide bond formation between amino acids results in the release of water (dehydration synthesis or condensation reaction). The protein backbone is characterized by the “N-C-C-N-C-C. .” pattern. The “ends” of the protein can be identified by the N-terminus (amino group) end and the C-terminus (carboxyl group) end. For a more complete lesson guide, please visit: http://www.3dmoleculardesigns.com/3DMD-Files/AABB/ContentsandAssembly.pdf Amino Acid Core Structure Build an amino acid according to the diagram to the right: 1. Identify the alpha carbon, amino group, carboxyl group and R-group (sidechain representation) in the structure you have constructed. Two amino acids can be chemically linked by a reaction called “condensation” or “dehydration synthesis” to form a dipeptide bond linking the two amino acids. A chain of amino acid units (monomers) linked together by peptide bonds is called a polypeptide. General Dipeptide Structure Construct a model of a dipeptide using the amino acid models previously built. 2. What are the products of the condensation reaction (dehydration synthesis)? 3.
    [Show full text]
  • Distinct Contributions of DNA Methylation and Histone Acetylation to the Genomic Occupancy of Transcription Factors
    Downloaded from genome.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Research Distinct contributions of DNA methylation and histone acetylation to the genomic occupancy of transcription factors Martin Cusack,1 Hamish W. King,2 Paolo Spingardi,1 Benedikt M. Kessler,3 Robert J. Klose,2 and Skirmantas Kriaucionis1 1Ludwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, United Kingdom; 2Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, United Kingdom; 3Target Discovery Institute, University of Oxford, Oxford, OX3 7FZ, United Kingdom Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are often governed by multilayered structure, how individual pathways contribute to gene expression remains poorly under- stood. For example, DNA methylation is known to regulate transcription factor binding but also to recruit methyl-CpG binding proteins that affect chromatin structure through the activity of histone deacetylase complexes (HDACs). Both of these mechanisms can potentially affect gene expression, but the importance of each, and whether these activities are inte- grated to achieve appropriate gene regulation, remains largely unknown. To address this important question, we measured gene expression, chromatin accessibility, and transcription factor occupancy in wild-type or DNA methylation-deficient mouse embryonic stem cells following HDAC inhibition. We observe widespread increases in chromatin accessibility at ret- rotransposons when HDACs are inhibited, and this is magnified when cells also lack DNA methylation. A subset of these elements has elevated binding of the YY1 and GABPA transcription factors and increased expression. The pronounced ad- ditive effect of HDAC inhibition in DNA methylation–deficient cells demonstrates that DNA methylation and histone deacetylation act largely independently to suppress transcription factor binding and gene expression.
    [Show full text]
  • Small Nucleolar Rnas Determine Resistance to Doxorubicin in Human Osteosarcoma
    International Journal of Molecular Sciences Article Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma Martina Godel 1, Deborah Morena 1, Preeta Ananthanarayanan 1, Ilaria Buondonno 1, Giulio Ferrero 2,3 , Claudia M. Hattinger 4, Federica Di Nicolantonio 1,5 , Massimo Serra 4 , 1 2 1, , 1, , Riccardo Taulli , Francesca Cordero , Chiara Riganti * y and Joanna Kopecka * y 1 Department of Oncology, University of Torino, 1026 Torino, Italy; [email protected] (M.G.); [email protected] (D.M.); [email protected] (P.A.); [email protected] (I.B.); [email protected] (F.D.N.); [email protected] (R.T.) 2 Department of Computer Science, University of Torino, 10149 Torino, Italy; [email protected] (G.F.); [email protected] (F.C.) 3 Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy 4 Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] (C.M.H.); [email protected] (M.S.) 5 Candiolo Cancer Institute, FPO–IRCCS, 10060 Candiolo, Italy * Correspondence: [email protected] (C.R.); [email protected] (J.K.); Tel.: +39-0116705857 (C.R.); +39-0116705849 (J.K.) These authors equally contributed to this work. y Received: 31 May 2020; Accepted: 21 June 2020; Published: 24 June 2020 Abstract: Doxorubicin (Dox) is one of the most important first-line drugs used in osteosarcoma therapy. Multiple and not fully clarified mechanisms, however, determine resistance to Dox. With the aim of identifying new markers associated with Dox-resistance, we found a global up-regulation of small nucleolar RNAs (snoRNAs) in human Dox-resistant osteosarcoma cells.
    [Show full text]
  • Ubiquitination/Deubiquitination and Acetylation/Deacetylation
    Acta Pharmacologica Sinica (2011) 32: 139–140 npg © 2011 CPS and SIMM All rights reserved 1671-4083/11 $32.00 www.nature.com/aps Research Highlight Ubiquitination/deubiquitination and acetylation/ deacetylation: Making DNMT1 stability more coordinated Qi HONG, Zhi-ming SHAO* Acta Pharmacologica Sinica (2011) 32: 139–140; doi: 10.1038/aps.2011.3 n mammals, DNA methylation plays important role in human cancers[7, 8]. abundance of DNMT1 mutant lacking Ia crucial role in the regulation of Ubiquitin­proteasome pathway is sig­ the HAUSP interaction domain, but not gene expression, telomere length, cell nificant in the stability of DNMT1[8], but the full­length protein. These results differentiation, X chromosome inactiva­ ubiquitin­mediated protein degradation show the coordination between ubiquit­ tion, genomic imprinting and tumori­ can be enhanced or attenuated by some ination of DNMT1 by UHRF1 and deu­ genesis[1]. DNA methylation patterns modifications like acetylation/deacety­ biquitination by HAUSP. Furthermore, are established de novo by DNA meth­ lation, protein methylation/demethyla­ they found that knockdown of HDAC1 yltransferases (DNMTs) 3a and 3b, tion, phosphorylation and S­nitrosy­ increased DNMT1 acetylation, and whereas DNMT1 maintains the parent­ lation[9–11]. Estève et al demonstrated reduced DNMT1 abundance. Addition­ specific methylation from parental cells that SET7­mediated lysine methy lation ally, acetyltransferase Tip60 which was to their progeny[2]. After DNA replica­ of DNMT1 decreased DNMT1 level found to acetylate DNMT1 promoted its tion, the new DNA strand is unmethy­ by ubiquitin­mediated degradation[10]. ubiquitination, then destabilized it. At lated. Thus with the mother methylated Furthermore, an early study[12] showed last, Tip60 and HAUSP were found to strand, the DNA is hemimethylated.
    [Show full text]
  • Introduction to Proteins and Amino Acids Introduction
    Introduction to Proteins and Amino Acids Introduction • Twenty percent of the human body is made up of proteins. Proteins are the large, complex molecules that are critical for normal functioning of cells. • They are essential for the structure, function, and regulation of the body’s tissues and organs. • Proteins are made up of smaller units called amino acids, which are building blocks of proteins. They are attached to one another by peptide bonds forming a long chain of proteins. Amino acid structure and its classification • An amino acid contains both a carboxylic group and an amino group. Amino acids that have an amino group bonded directly to the alpha-carbon are referred to as alpha amino acids. • Every alpha amino acid has a carbon atom, called an alpha carbon, Cα ; bonded to a carboxylic acid, –COOH group; an amino, –NH2 group; a hydrogen atom; and an R group that is unique for every amino acid. Classification of amino acids • There are 20 amino acids. Based on the nature of their ‘R’ group, they are classified based on their polarity as: Classification based on essentiality: Essential amino acids are the amino acids which you need through your diet because your body cannot make them. Whereas non essential amino acids are the amino acids which are not an essential part of your diet because they can be synthesized by your body. Essential Non essential Histidine Alanine Isoleucine Arginine Leucine Aspargine Methionine Aspartate Phenyl alanine Cystine Threonine Glutamic acid Tryptophan Glycine Valine Ornithine Proline Serine Tyrosine Peptide bonds • Amino acids are linked together by ‘amide groups’ called peptide bonds.
    [Show full text]
  • 1519038862M28translationand
    Paper No. : 15 Molecular Cell Biology Module : 28 Translation and Post-translation Modifications in Eukaryotes Development Team Principal Investigator : Prof. Neeta Sehgal Department of Zoology, University of Delhi Co-Principal Investigator : Prof. D.K. Singh Department of Zoology, University of Delhi Paper Coordinator : Prof. Kuldeep K. Sharma Department of Zoology, University of Jammu Content Writer : Dr. Renu Solanki, Deen Dayal Upadhyaya College Dr. Sudhida Gautam, Hansraj College, University of Delhi Mr. Kiran K. Salam, Hindu College, University of Delhi Content Reviewer : Prof. Rup Lal Department of Zoology, University of Delhi 1 Molecular Genetics ZOOLOGY Translation and Post-translation Modifications in Eukaryotes Description of Module Subject Name ZOOLOGY Paper Name Molecular Cell Biology; Zool 015 Module Name/Title Cell regulatory mechanisms Module Id M28: Translation and Post-translation Modifications in Eukaryotes Keywords Genome, Proteome diversity, post-translational modifications, glycosylation, phosphorylation, methylation Contents 1. Learning Objectives 2. Introduction 3. Purpose of post translational modifications 4. Post translational modifications 4.1. Phosphorylation, the addition of a phosphate group 4.2. Methylation, the addition of a methyl group 4.3. Glycosylation, the addition of sugar groups 4.4. Disulfide bonds, the formation of covalent bonds between 2 cysteine amino acids 4.5. Proteolysis/ Proteolytic Cleavage 4.6. Subunit binding to form a multisubunit protein 4.7. S-nitrosylation 4.8. Lipidation 4.9. Acetylation 4.10. Ubiquitylation 4.11. SUMOlytion 4.12. Vitamin C-Dependent Modifications 4.13. Vitamin K-Dependent Modifications 4.14. Selenoproteins 4.15. Myristoylation 5. Chaperones: Role in PTM and mechanism 6. Role of PTMs in diseases 7. Detecting and Quantifying Post-Translational Modifications 8.
    [Show full text]
  • Transcriptional Regulation by Histone Ubiquitination and Deubiquitination
    Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE Transcriptional regulation by histone ubiquitination and deubiquitination Yi Zhang1 Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina 27599, USA Ubiquitin (Ub) is a 76-amino acid protein that is ubiqui- The fact that histone ubiquitination occurs in the largely tously distributed and highly conserved throughout eu- monoubiquitinated form and is not linked to degrada- karyotic organisms. Whereas the extreme C-terminal tion, in combination with the lack of information regard- four amino acids are in a random coil, its N-terminal 72 ing the responsible enzymes, prevented us from under- amino acids have a tightly folded globular structure (Vi- standing the functional significance of this modification. jay-Kumar et al. 1987; Fig. 1A). Since its discovery ∼28 Recent identification of the E2 and E3 proteins involved years ago (Goldknopf et al. 1975), a variety of cellular in H2B ubiquitination (Robzyk et al. 2000; Hwang et al. processes including protein degradation, stress response, 2003; Wood et al. 2003a) and the discovery of cross-talk cell-cycle regulation, protein trafficking, endocytosis sig- between histone methylation and ubiquitination (Dover naling, and transcriptional regulation have been linked et al. 2002; Sun and Allis 2002) have set the stage for to this molecule (Pickart 2001). Ubiquitylation is pro- functional analysis of histone ubiquitination. In a timely posed to serve as a signaling module, and the informa- paper published in the previous issue of Genes & Devel- tion transmitted by this tag may depend on the nature of opment, Shelley Berger and colleagues (Henry et al.
    [Show full text]
  • Introduction 1.1 Post-Translational Modifications
    Chapter I: Introduction 1.1 Post-translational modifications Post-translational modifications (PTMs) are responsible for dynamic regulation of protein structure and function (Jensen et al., 2006). One example of the function of post-translational modifications in the dynamic regulation of protein structure and function is signal transduction; post-translational modification of key regulatory proteins in signal transduction pathways controls cellular proliferation, metabolism, gene expression, cytoskeletal organization and apoptosis (Jensen et al., 2006). Post-translational modifications not only change the mass of the protein, they are also often responsible for changes in charge, structure and conformation. This leads to changes in the biological activity of proteins like enzymes, the binding affinity of proteins to receptors and other protein-protein interactions (Hoffmann et al., 2008) (Murray et al., 1998). For example, the interaction of the cytokine TGF-beta with its receptor complex results in the phosphorylation of SMAD family proteins which activates these proteins to regulate target gene expression (Massague et al., 2000). Post-translational modified amino acid residues can act as binding sites on proteins for a specific recognition domain on other proteins. For example, phosphorylated tyrosine residues can bind to SH2 or PTB domains (Pawson et al., 1997). Depending on the type of PTM they can be very abundant and have a large number of target proteins, whereas other PTM`s have only a few target proteins. Moreover, some PTM`s are connected with several different residues and not only with one residue. For example multi-site phosphorylation that primarily targets Serine, Threonine and Tyrosine residues is a crucial mechanism for the regulation of protein localization and functional activity (Cohen et al., 2000).
    [Show full text]
  • Peptides & Proteins
    Peptides & Proteins (thanks to Hans Börner) 1 Proteins & Peptides Proteuos: Proteus (Gr. mythological figure who could change form) proteuo: „"first, ref. the basic constituents of all living cells” peptos: „Cooked referring to digestion” Proteins essential for: Structure, metabolism & cell functions 2 Bacterium Proteins (15 weight%) 50% (without water) • Construction materials Collagen Spider silk proteins 3 Proteins Structural proteins structural role & mechanical support "cell skeleton“: complex network of protein filaments. muscle contraction results from action of large protein assemblies Myosin und Myogen. Other organic material (hair and bone) are also based on proteins. Collagen is found in all multi cellular animals, occurring in almost every tissue. • It is the most abundant vertebrate protein • approximately a quarter of mammalian protein is collagen 4 Proteins Storage Various ions, small molecules and other metabolites are stored by complexation with proteins • hemoglobin stores oxygen (free O2 in the blood would be toxic) • iron is stored by ferritin Transport Proteins are involved in the transportation of particles ranging from electrons to macromolecules. • Iron is transported by transferrin • Oxygen via hemoglobin. • Some proteins form pores in cellular membranes through which ions pass; the transport of proteins themselves across membranes also depends on other proteins. Beside: Regulation, enzymes, defense, functional properties 5 Our universal container system: Albumines 6 zones: IA, IB, IIA, IIB, IIIA, IIIB; IIB and
    [Show full text]
  • How Genes Work
    Help Me Understand Genetics How Genes Work Reprinted from MedlinePlus Genetics U.S. National Library of Medicine National Institutes of Health Department of Health & Human Services Table of Contents 1 What are proteins and what do they do? 1 2 How do genes direct the production of proteins? 5 3 Can genes be turned on and off in cells? 7 4 What is epigenetics? 8 5 How do cells divide? 10 6 How do genes control the growth and division of cells? 12 7 How do geneticists indicate the location of a gene? 16 Reprinted from MedlinePlus Genetics (https://medlineplus.gov/genetics/) i How Genes Work 1 What are proteins and what do they do? Proteins are large, complex molecules that play many critical roles in the body. They do most of the work in cells and are required for the structure, function, and regulation of thebody’s tissues and organs. Proteins are made up of hundreds or thousands of smaller units called amino acids, which are attached to one another in long chains. There are 20 different types of amino acids that can be combined to make a protein. The sequence of amino acids determineseach protein’s unique 3-dimensional structure and its specific function. Aminoacids are coded by combinations of three DNA building blocks (nucleotides), determined by the sequence of genes. Proteins can be described according to their large range of functions in the body, listed inalphabetical order: Antibody. Antibodies bind to specific foreign particles, such as viruses and bacteria, to help protect the body. Example: Immunoglobulin G (IgG) (Figure 1) Enzyme.
    [Show full text]
  • Structure and Synthesis of Antifungal Disulfide
    microorganisms Review Structure and Synthesis of Antifungal Disulfide β-Strand Proteins from Filamentous Fungi Györgyi Váradi 1,*, Gábor K. Tóth 1,2 and Gyula Batta 3 1 Department of Medical Chemistry, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary; [email protected] 2 MTA-SZTE Biomimetic Systems Research Group, University of Szeged, H-6720 Szeged, Hungary 3 Department of Organic Chemistry, University of Debrecen, H-4032 Debrecen, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +36-62-545-142; Fax: +36-62-545-971 Received: 20 November 2018; Accepted: 24 December 2018; Published: 27 December 2018 Abstract: The discovery and understanding of the mode of action of new antimicrobial agents is extremely urgent, since fungal infections cause 1.5 million deaths annually. Antifungal peptides and proteins represent a significant group of compounds that are able to kill pathogenic fungi. Based on phylogenetic analyses the ascomycetous, cysteine-rich antifungal proteins can be divided into three different groups: Penicillium chrysogenum antifungal protein (PAF), Neosartorya fischeri antifungal protein 2 (NFAP2) and “bubble-proteins” (BP) produced, for example, by P. brevicompactum. They all dominantly have β-strand secondary structures that are stabilized by several disulfide bonds. The PAF group (AFP antifungal protein from Aspergillus giganteus, PAF and PAFB from P. chrysogenum, Neosartorya fischeri antifungal protein (NFAP)) is the best characterized with their common β-barrel tertiary structure. These proteins and variants can efficiently be obtained either from fungi production or by recombinant expression. However, chemical synthesis may be a complementary aid for preparing unusual modifications, e.g., the incorporation of non-coded amino acids, fluorophores, or even unnatural disulfide bonds.
    [Show full text]